EN
抗体药类似物
Research Grade Surzebiclimab
All
  • CatalogTD-HV029036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBGB-A425,CAS:2342597-90-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Surzebiclimab


Catalog No. TD-HV029036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-Kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target T-cell immunoglobulin mucin receptor 3, HAVcr-2, TIMD-3, T-cell membrane protein 3, HAVCR2, Hepatitis A virus cellular receptor 2, CD366, TIMD3, TIM-3, TIM3, T-cell immunoglobulin and mucin domain-containing protein 3
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q8TDQ0
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BGB-A425,CAS:2342597-90-2
Background Surzebiclimab (BGB-A425) is a humanized IgG1-variant monoclonal antibody against T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). Surzebiclimab binds to the extracellular domain of human Tim-3 with high affinity (KD=0.36 nM) and specificity. Surzebiclimab can be used in research of cancer.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV029036_1.jpg
Bioactivity
 
Detects CD366/HAVCR2/TIM-3 in indirect ELISAs.